These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 26822359)
1. PET imaging for addiction medicine: From neural mechanisms to clinical considerations. Wiers CE; Cabrera E; Skarda E; Volkow ND; Wang GJ Prog Brain Res; 2016; 224():175-201. PubMed ID: 26822359 [TBL] [Abstract][Full Text] [Related]
2. PET imaging in clinical drug abuse research. Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850 [TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography molecular imaging of dopaminergic system in drug addiction. Hou H; Tian M; Zhang H Anat Rec (Hoboken); 2012 May; 295(5):722-33. PubMed ID: 22467195 [TBL] [Abstract][Full Text] [Related]
4. What is the role of the D3 receptor in addiction? A mini review of PET studies with [(11)C]-(+)-PHNO. Payer D; Balasubramaniam G; Boileau I Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jul; 52():4-8. PubMed ID: 23999545 [TBL] [Abstract][Full Text] [Related]
5. Imaging the D3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies with [(11)C]-(+)-PHNO. Boileau I; Nakajima S; Payer D Eur Neuropsychopharmacol; 2015 Sep; 25(9):1410-20. PubMed ID: 26141509 [TBL] [Abstract][Full Text] [Related]
6. Cocaine addiction: hypothesis derived from imaging studies with PET. Volkow ND; Ding YS; Fowler JS; Wang GJ J Addict Dis; 1996; 15(4):55-71. PubMed ID: 8943582 [TBL] [Abstract][Full Text] [Related]
7. PET imaging studies in drug abuse. Fowler JS; Volkow ND J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971 [TBL] [Abstract][Full Text] [Related]
8. Functional neuroimaging for addiction medicine: From mechanisms to practical considerations. Ekhtiari H; Faghiri A; Oghabian MA; Paulus MP Prog Brain Res; 2016; 224():129-53. PubMed ID: 26822357 [TBL] [Abstract][Full Text] [Related]
11. Imaging neurotransmitter release by drugs of abuse. Martinez D; Narendran R Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755 [TBL] [Abstract][Full Text] [Related]
12. Imaging addiction with PET: is insight in sight? Schiffer WK; Lee DE; Brodie JD; Dewey SL Drug Discov Today; 2005 Apr; 10(8):547-62. PubMed ID: 15837598 [TBL] [Abstract][Full Text] [Related]
13. Similarities and Differences in Neuroimaging. Sun YK; Sun Y; Lin X; Lu L; Shi J Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669 [TBL] [Abstract][Full Text] [Related]
14. Nonhuman primate models of addiction and PET imaging: dopamine system dysregulation. Gould RW; Porrino LJ; Nader MA Curr Top Behav Neurosci; 2012; 11():25-44. PubMed ID: 22020537 [TBL] [Abstract][Full Text] [Related]
15. Food addiction: A common neurobiological mechanism with drug abuse. Lindgren E; Gray K; Miller G; Tyler R; Wiers CE; Volkow ND; Wang GJ Front Biosci (Landmark Ed); 2018 Jan; 23(5):811-836. PubMed ID: 28930574 [TBL] [Abstract][Full Text] [Related]
17. Brain dopaminergic system changes in drug addiction: a review of positron emission tomography findings. Hou H; Wang C; Jia S; Hu S; Tian M Neurosci Bull; 2014 Oct; 30(5):765-76. PubMed ID: 25260796 [TBL] [Abstract][Full Text] [Related]